This study aims to evaluate differences in treatment modalities including use of insulin and metformin in relation to different degrees of obesity in pregnant women affected by GDM, taking into special consideration dosing regimens of basal insulin and rapid acting formulations. This evidence concerns the gene INS and Obesity.